Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29463886 | 1.00 | TDP1 (0.44) | TDP1IDO1HTTMTNR1AMTNR1B | |
| SCHEMBL15205675 | 0.90 | HDAC1 (0.47) | TDP1IDO1HTTMTNR1AMTNR1B | |
| SCHEMBL15205395 | 0.87 | MAPT (0.49) | TDP1HTTEGLN3NPC1RAB9A | |
| SCHEMBL483805 | 0.83 | TDP1 (0.44) | TDP1IDO1HTTMTNR1AMTNR1B | |
| SCHEMBL15205558 | 0.81 | EGLN3 (0.64) | TDP1IDO1HTTMTNR1AMTNR1B | |
| SCHEMBL22155671 | 0.81 | MCL1 (0.43) | TDP1IDO1MTNR1AMTNR1BEGLN3 | |
| SCHEMBL15272387 | 0.81 | LMNA (0.60) | TDP1HTTNPC1RAB9AMAPT | |
| SCHEMBL9597231 | 0.80 | TDP1 (0.44) | TDP1HTTMTNR1AMTNR1BEGLN3 | |
| SCHEMBL9597846 | 0.80 | TNF (0.46) | TDP1HTTMTNR1AMTNR1BEGLN3 | |
| SCHEMBL259900 | 0.80 | PRPS1 (0.51) | TDP1HTTMTNR1AMTNR1BEGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023146511-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| CN-116456985-A | Pyrimidine and pyridine derivatives as HPK1 modulators and methods of use thereof | 深圳市原力生命科学有限公司 | 2023-07-18 | — | — | CN | disclosed |
| WO-2021139775-A1 | PYRIDONE COMPOUND AND APPLICATION | 江苏先声药业有限公司 | 2021-07-15 | — | — | WO | disclosed |
| EP-3348547-B1 | BENZIMIDAZOLE DERIVATIVES AS NAV 1.7 (SODIUM CHANNEL, VOLTAGE-GATED, TYPE IX, ALPHA SUBUNIT (SCN9A)) INHIBITORS FOR TREATING PAIN, DYSURIA AND MULTIPLE SCLEROSIS | SUMITOMO DAINIPPON PHARMA CO LTD (JP) | 2020-07-22 | — | — | EP | disclosed |
| US-10407395-B2 | Benzimidazole compound and medical use thereof | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2019-09-10 | — | — | US | disclosed |
| US-10040767-B2 | Benzimidazole derivatives and uses thereof | PELOTON THERAPEUTICS, INC. (US) | 2018-08-07 | — | — | US | disclosed |
| EP-3348547-A1 | NOVEL BENZIMIDAZOLE COMPOUND AND PHARMACEUTICAL USE OF SAME | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2018-07-18 | — | — | EP | disclosed |
| US-20180170881-A1 | NOVEL BENZIMIDAZOLE COMPOUND AND MEDICAL USE THEREOF | Sumitomo Pharma Co., Ltd. (JP) | 2018-06-21 | — | — | US | disclosed |
| US-20180170881-A1 | NOVEL BENZIMIDAZOLE COMPOUND AND MEDICAL USE THEREOF | Sumitomo Pharma Co., Ltd. (JP) | 2018-06-21 | — | — | US | disclosed |
| US-9688670-B2 | Benzimidazole compounds and medical uses thereof | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-06-27 | — | — | US | disclosed |
| US-9688670-B2 | Benzimidazole compounds and medical uses thereof | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-06-27 | — | — | US | disclosed |
| US-9688670-B2 | Benzimidazole compounds and medical uses thereof | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-06-27 | — | — | US | disclosed |
| US-20170107211-A1 | NOVEL BENZIMIDAZOLE COMPOUND AND MEDICAL USE THEREOF | Sumitomo Pharma Co., Ltd. (JP) | 2017-04-20 | — | — | US | disclosed |
| US-20170107211-A1 | NOVEL BENZIMIDAZOLE COMPOUND AND MEDICAL USE THEREOF | Sumitomo Pharma Co., Ltd. (JP) | 2017-04-20 | — | — | US | disclosed |
| US-20170107211-A1 | NOVEL BENZIMIDAZOLE COMPOUND AND MEDICAL USE THEREOF | Sumitomo Pharma Co., Ltd. (JP) | 2017-04-20 | — | — | US | disclosed |
| US-20170088523-A1 | BENZIMIDAZOLE DERIVATIVES AND USES THEREOF | PELOTON THERAPEUTICS, INC. | 2017-03-30 | — | — | US | disclosed |
| WO-2017043636-A1 | NOVEL BENZIMIDAZOLE COMPOUND AND PHARMACEUTICAL USE OF SAME | 大日本住友製薬株式会社 | 2017-03-16 | — | — | WO | disclosed |
| WO-2015175845-A1 | BENZIMIDAZOLE DERIVATIVES AND USES THEREOF | PELOTON THERAPEUTICS, INC. (US) | 2015-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170088523-A1 | BENZIMIDAZOLE DERIVATIVES AND USES THEREOF | ACSS2, GLS2, ACSL3 | TDP1 3937/4885IDO1 2076/4885HTT 4850/4885 |
| US-20170107211-A1 | NOVEL BENZIMIDAZOLE COMPOUND AND MEDICAL USE THEREOF | KCNA7, SCN1A, KCNA1 | TDP1 3596/4885IDO1 4267/4885HTT 2458/4885 |
| US-10407395-B2 | Benzimidazole compound and medical use thereof | SCN1B, SCN1A, KCNA7 | TDP1 3406/4885IDO1 3791/4885HTT 2428/4885 |
| US-20180170881-A1 | NOVEL BENZIMIDAZOLE COMPOUND AND MEDICAL USE THEREOF | KCNA7, SCN1A, KCNA1 | TDP1 3596/4885IDO1 4267/4885HTT 2458/4885 |
| US-10040767-B2 | Benzimidazole derivatives and uses thereof | ACSS2, GLS2, ACSL3 | TDP1 3937/4885IDO1 2076/4885HTT 4850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.